Authorisation and WHO listing for emergency use of Ebola rapid diagnostic test
Corgenix Medical Corporation announced it has received U.S. Food and Drug Administration (FDA) emergency use authorization (EUA) of its ReEBOVTM Antigen Rapid Test. The test is to be used for the presumptive detection of Ebola Zaire virus (detected in the West Africa outbreak in 2014) in individuals with signs and symptoms of Ebola virus infection […]
